Author:
Berezin P. G.,Milovanov V. V.,Ivannikov A. A.
Publisher
Media Sphere Publishing Group
Reference25 articles.
1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008. Cancer incidence and mortality worldwide: IARC Cancer Base No.10. Lyon, France: International Agency for Research on Cancer; 2010. Available at: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed March, 2015.
2. STUDIES ON PROSTATIC CANCER
3. FAILURE TO ACHIEVE CASTRATE LEVELS OF TESTOSTERONE DURING LUTEINIZING HORMONE RELEASING HORMONE AGONIST THERAPY: THE CASE FOR MONITORING SERUM TESTOSTERONE AND A TREATMENT DECISION ALGORITHM
4. A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer
5. Wechsel HW, Zerbib M, Pagano F, Coptcoal VJ. Randomized open labeled comparative study of the efficacy, safety and tolerability of leuprorelin acetate 1M and 3M depot in patients with advanced prostatic cancer. Eur Urol. 1996;30(Suppl. 1):7-14, discussion 19-21. PMID:8977984